Showing results (121-130 of 175) with videos related to
Sort By:
Pageof 18
American Heart Journal|February 26, 2008
Noninvasive, medical management for non-ST-elevation acute coronary syndromesMark Y Chan, Richard C Becker, Robert A Harrington, et al.Circulation|March 13, 2002
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?R John Simes, Ian C Marschner, David Hunt, et al.Coronary Artery Disease|April 14, 2018
Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes: insights from the TRILOGY ACS trialAndrew T Yan, Matthew T Roe, Megan Neely, et al.Circulation|September 5, 2015
Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50Erin A Bohula, Philip E Aylward, Marc P Bonaca, et al.American Heart Journal|January 31, 2006
Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarctionManesh R Patel, Trip J Meine, Lauren Lindblad, et al.The New Zealand Medical Journal|August 11, 2016
The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9)Andrew Kerr, Michael Ja Williams, Harvey White, et al.Neuropharmacology|July 17, 2007
Multiple pathways involved in the biosynthesis of anandamideJie Liu, Lei Wang, Judith Harvey-White, et al.International Journal of Molecular Sciences|July 15, 2026
Molecular and Biological Characterization of a Newly Identified Virus Representing a Novel Taxon of Alphaflexiviridae Infecting Different Accessions of Seashore Paspalum, a Turfgrass, Widely Grown in the United StatesSayanta Bera, Taylor F Schulden, Xiaojun Hu, et al.American Heart Journal|October 12, 2010
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart diseaseHarvey White, Claes Held, Ralph Stewart, et al.Journal of the American College of Cardiology|February 21, 2006
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)John McMurray, Scott Solomon, Karen Pieper, et al.Pageof 18